₨ 7,000
Glucantime is a medication used to treat leishmaniasis, an infection caused by tiny, one-celled organisms called protozoa. The medicine in the image contains meglumine antimoniate (1.5 g/5 ml) and is administered via intramuscular (IM) or local injection.
Key Information
- Active Ingredient: Meglumine antimoniate, a pentavalent antimony compound (SbV).
- Manufacturer: Sanofi.
- Form: Injectable solution (5 ampoules of 5 ml).
- Usage: It is the first-choice drug recommended by the World Health Organization (WHO) for the treatment of all forms of leishmaniasis, including cutaneous (skin lesions), mucocutaneous, and visceral (kala-azar or black sickness) leishmaniasis, especially in regions where the parasites are not resistant to antimony.
- Administration: It can be injected into a muscle or directly into skin lesions. A full course of treatment typically lasts several weeks.
- Side Effects: Common side effects include pain at the injection site, fever, nausea, vomiting, and muscle/joint pain. More serious adverse effects can include liver or kidney complications.
Disclaimer: This information is for informational purposes only. Meglumine antimoniate should only be administered by or under the supervision of a doctor due to potential side effects and the need for proper dosing and monitoring.
₨ 10,000
